Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
genetics
ally bridge group
belgian startups
big data analytics
blackrock
boston
boston blog main
boston top stories
casdin capital
clinical trials
color genomics
diabetic nephropathy
eventide asset management
features
focal segmental glomerulosclerosis
free
genetic testing
genomics
globachem
goldfinch bio
irving investors
jay ghosh
life sciences
medicine
national blog main
national top stories
precision agriculture
precision medicine
schroeder adveq
software
tc
third rock ventures
verily
wellington management company
yonjin capital
What
analysis
4
×
company
4
×
genetic
4
×
company’s
diseases
million
raised
raises
technology
testing
tests
agriculture
alphabet’s
alzheimer’s
andme
applications
approval
baseline
belgian
bio
biostrand
biotech
biotechnology
bring
business
celiac
cleared
color
comes
companies
conditions
consumer
continue
crop
customers
data
develop
developing
direct
disease
Language
unset
Current search:
company
×
analysis
×
genetic
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@tech.eu
3 years ago
Belgian startup BioStrand raises €2 million to disrupt genetic data analysis
@techcrunch.com
4 years ago
Verily, Alphabet’s other money-making, non-Google business, partners with Color on genetic analysis
@theverge.com
7 years ago
No doctor required: 23andMe cleared by FDA for at-home DNA tests
